Five Below (FIVE) PT Lowered at UBS Despite 'Solid' Q3 Beat

Go back to Five Below (FIVE) PT Lowered at UBS Despite 'Solid' Q3 Beat

After-Hours Stock Movers 12/03: (KBIO) (FIVE) (TRVN) Higher; (ZUMZ) (BKS) (COO) Lower (more...)

December 3, 2015 5:59 PM EST

KaloBios Pharma (NASDAQ: KBIO) 33.8% HIGHER; announced that it has signed an agreement to acquire a benznidazole program for the treatment of Chagas Disease from Savant Neglected Diseases, LLC, a privately-held specialty pharmaceutical company. Under the terms of the agreement, KaloBios will pay an upfront payment of $2 million, plus regulatory milestones and a royalty based on product sales. The transaction is expected to close in the coming weeks. Also announced it has entered definitive agreements with institutional and accredited investors in connection with a private placement, or PIPE... More

Five Below (FIVE) Tops Q3 EPS by 1c, Offers Q4 Guidance

December 3, 2015 4:02 PM EST

Five Below (NASDAQ: FIVE) reported Q3 EPS of $0.08, $0.01 better than the analyst estimate of $0.07. Revenue for the quarter came in at $169.7 million versus the consensus estimate of $166.6 million.

GUIDANCE:

Five Below sees Q4 2015 EPS of $0.74-$0.76, versus the consensus... More

Trading Radar for 12/3: Kroger (KR), Express (EXPR), Dollar General (DG), Ambarella (AMBA) Report

December 2, 2015 2:41 PM EST

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
7:00am EST

Challenger Job Cuts - no Street consensus

8:30am EST

Initial Claims - Street sees 267kContinuing Claims - Street sees 2.177M

Earnings:

Canadian Imperial Bank (NYSE:... More